We are live on
!
Find out more
DnB Asset Management Portfolio holdings
AUM
$35.7B
1-Year Est. Return
27.58%
This Fund
S&P 500
This Quarter
Est. Return
+18.58%
1 Year Est. Return
+27.58%
3 Year Est. Return
+110%
5 Year Est. Return
+135.26%
10 Year Est. Return
+538.97%
AUM
$35.7B
AUM Growth
+$7.67B
(+27%)
Cap. Flow
+$3.99B
Cap. Flow
% of AUM
11.17%
Top 10 Holdings %
Top 10 Hldgs %
44.35%
Holding
1,360
New
125
Increased
416
Reduced
428
Closed
84
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$673M |
| 2 |
Visa
V
|
+$517M |
| 3 |
Microsoft
MSFT
|
+$459M |
| 4 |
Mastercard
MA
|
+$413M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$355M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$356M |
| 2 |
Oracle
ORCL
|
+$255M |
| 3 |
Qualcomm
QCOM
|
+$182M |
| 4 |
Advanced Micro Devices
AMD
|
+$89.2M |
| 5 |
Waste Management
WM
|
+$88.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.73% |
| 2 | Communication Services | 13.99% |
| 3 | Financials | 13.87% |
| 4 | Consumer Discretionary | 10.7% |
| 5 | Healthcare | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Microbot Medical
MBOT
$114M
| $1.32M | ﹤0.01% |
677,498
| – | – |
|
627
BridgeBio Pharma
BBIO
$15.8B
| $1.31M | ﹤0.01% |
17,555
+714
| +4% | +$50K |
|
628
Blue Owl Capital
OBDC
$5.89B
| $1.28M | ﹤0.01% |
117,961
-102,415
| -46% | -$1.15M |
|
629
MidCap Financial Investment
MFIC
$811M
| $1.28M | ﹤0.01% |
127,082
-26,276
| -17% | -$289K |
|
630
Rhythm Pharmaceuticals
RYTM
$8.01B
| $1.27M | ﹤0.01% |
11,465
+270
| +2% | +$24.4K |
|
631
Gladstone Capital
GLAD
$451M
| $1.24M | ﹤0.01% |
63,933
-13,592
| -18% | -$258K |
|
632
Akamai
AKAM
$17.9B
| $1.22M | ﹤0.01% |
10,345
+3,440
| +50% | +$428K |
|
633
ZTO Express
ZTO
$17.4B
| $1.14M | ﹤0.01% |
51,108
-1,396
| -3% | -$33.2K |
|
634
US Foods
USFD
$23.9B
| $1.09M | ﹤0.01% |
10,708
-30,645
| -74% | -$2.73M |
|
635
Futu Holdings
FUTU
$14.6B
| $1.08M | ﹤0.01% |
11,552
-6,081
| -34% | -$779K |
|
636
Cytokinetics
CYTK
$10.3B
| $1.08M | ﹤0.01% |
12,676
-222
| -2% | -$15.9K |
|
637
TTM Technologies
TTMI
$14.5B
| $1.07M | ﹤0.01% |
5,726
+270
| +5% | +$43.5K |
|
|
SERV
638
Serve Robotics
SERV
$429M
| $1.07M | ﹤0.01% |
162,225
-20,146
| -11% | -$168K |
|
639
Alkermes
ALKS
$8.29B
| $1.07M | ﹤0.01% |
20,328
-10,197
| -33% | -$398K |
|
640
Vaxcyte
PCVX
$8.76B
| $1.05M | ﹤0.01% |
18,041
-1,059
| -6% | -$57.5K |
|
641
XP
XP
$8.19B
| $1.03M | ﹤0.01% |
63,338
+7,137
| +13% | +$127K |
|
642
Huazhu Hotels Group
HTHT
$12.5B
| $1.03M | ﹤0.01% |
24,681
+244
| +1% | +$11.6K |
|
643
Main Street Capital
MAIN
$5.53B
| $1.01M | ﹤0.01% |
19,520
-5,109
| -21% | -$269K |
|
644
Power Integrations
POWI
$3.48B
| $995K | ﹤0.01% |
11,885
+7,759
| +188% | +$560K |
|
645
Scholar Rock
SRRK
$6.43B
| $988K | ﹤0.01% |
17,972
-3,986
| -18% | -$193K |
|
646
NIO
NIO
$11.3B
| $983K | ﹤0.01% |
194,288
-25,326
| -12% | -$148K |
|
647
Lattice Semiconductor
LSCC
$18.3B
| $981K | ﹤0.01% |
6,412
-515
| -7% | -$66.5K |
|
648
Hyliion Holdings
HYLN
$732M
| $946K | ﹤0.01% |
+182,709
| New | +$760K |
|
649
Lightpath Technologies
LPTH
$824M
| $924K | ﹤0.01% |
56,538
-67,381
| -54% | -$940K |
|
650
SiTime
SITM
$20.6B
| $919K | ﹤0.01% |
1,233
+48
| +4% | +$30.3K |
|
Similar funds
VIA
DnB Asset Management's Q2 2026 Portfolio in Review
As of Q2 2026, DnB Asset Management held 1,360 positions worth $35.7B, up 27% from $28B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
DnB Asset Management deployed $3.99B of net new capital in Q2 2026, opening 125 new positions and adding to 416 existing holdings. Its largest new stake was GFL Environmental: 2,189,821 shares worth $80.6M.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 37% a quarter earlier, followed by Communication Services and Financials.
On the sell side, the largest reduction was Marvell Technology, an estimated $356M trimmed.
- DnB Asset Management's largest Q2 2026 buy was GFL Environmental: 2,189,821 shares worth $80.6M.
- DnB Asset Management added most to Broadcom in Q2 2026, an estimated $673M increase.
- DnB Asset Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $356M.
- DnB Asset Management fully exited Vista Energy in Q2 2026, selling an estimated $14.4M.
- DnB Asset Management's ten largest holdings make up 44% of its $35.7B portfolio in Q2 2026.
- DnB Asset Management opened 125 new positions and closed 84 in Q2 2026.
- DnB Asset Management's portfolio value rose 27% quarter-over-quarter to $35.7B.
Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.